Mexidol amp 50mg/ml 2ml N10 (Vectorfarm)

IM or IV (stream or drip).

When administered by infusion, the drug should be diluted in 0.9% sodium chloride solution.

Mexidol® is injected slowly over 5-7 minutes in a stream, and dropwise at a rate of 40-60 drops per minute. The maximum daily dose should not exceed 1200 mg.

For acute cerebrovascular accidents

Mexidol® is used in the first 10-14 days - 200-500 mg IV drip 2-4 times a day, then 200-250 mg IM 2-3 times a day for 2 weeks.

For traumatic brain injury and consequences of traumatic brain injury

Mexidol® is used for 10-15 days intravenously at a dose of 200-500 mg 2-4 times a day.

For dyscirculatory encephalopathy in the decompensation phase

Mexidol® should be prescribed intravenously in a stream or drip at a dose of 200-500 mg 1
-
2 times a day for 14 days. Then IM 100-250 mg/day. over the next 2 weeks.

For course prophylaxis of dyscirculatory encephalopathy

the drug is administered intramuscularly at a dose of 200-250 mg 2 times a day for 10-14 days.

For mild cognitive impairment in elderly patients and anxiety disorders

the drug is used intramuscularly at a daily dose of 100-300 mg/day for 14-30 days.

In acute myocardial infarction as part of complex therapy

Mexidol® is administered intravenously or intramuscularly for 14 days, against the background of traditional therapy for myocardial infarction, including nitrates, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, thrombolytics, anticoagulant and antiplatelet agents, as well as symptomatic agents according to indications.

In the first 5 days, to achieve maximum effect, it is advisable to administer the drug intravenously; in the next 9 days, Mexidol® can be administered intramuscularly. Intravenous administration of the drug is carried out by drip infusion, slowly (to avoid side effects) in a 0.9% sodium chloride solution or 5% dextrose (glucose) solution in a volume of 100-150 ml for 30-90 minutes. If necessary, a slow jet injection of the drug, lasting at least 5 minutes, is possible.

The drug is administered (intravenous or intramuscular) 3 times a day, every 8 hours. The daily therapeutic dose is 6-9 mg/kg body weight per day, a single dose is 2-3 mg/kg body weight. The maximum daily dose should not exceed 800 mg, single dose - 250 mg.

For open-angle glaucoma of various stages as part of complex therapy

Mexidol® is administered intramuscularly at 100-300 mg/day, 1-3 times a day for 14 days.

For alcohol withdrawal syndrome

Mexidol® is administered in a dose of 200-500 mg intravenously or intramuscularly 2-3 times a day for 5-7 days.

In case of acute intoxication with antipsychotic drugs

the drug is administered intravenously at a dose of 200-500 mg/day for 7-14 days.

In acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis)

the drug is prescribed on the first day both in the preoperative and postoperative periods. The administered doses depend on the form and severity of the disease, the prevalence of the process, and variants of the clinical course. The drug should be discontinued gradually only after a stable positive clinical and laboratory effect.

For acute edematous (interstitial) pancreatitis

Mexidol® is prescribed 200-500 mg 3 times a day, intravenously (in 0.9% sodium chloride solution) and intramuscularly.

Mild severity of necrotizing
pancreatitis
- 100-200 mg 3 times a day intravenously (in 0.9% sodium chloride solution) and intramuscularly.

Moderate severity

- 200 mg 3 times a day, intravenously (in 0.9% sodium chloride solution).

Severe course

— in a pulse dosage of 800 mg on the first day, with a two-time administration regimen; then 200-500 mg 2 times a day with a gradual reduction in the daily dose.

Extremely severe course

- at an initial dosage of 800 mg/day until the manifestations of pancreatogenic shock are persistently relieved, upon stabilization of the condition, 300-500 mg 2 times a day intravenously (in 0.9% sodium chloride solution) with a gradual decrease in the daily dosage.

Mexidol injection solution 50 mg/ml 2 ml ampoules 10 pcs. in Moscow

IV (stream or drip) or IM.

When administered by infusion, the drug should be diluted in an isotonic sodium chloride solution.

Mexidol® is administered slowly over 5–7 minutes in a stream, and dropwise at a rate of 40–60 drops per minute. The maximum daily dose should not exceed 1200 mg.

For acute cerebrovascular accidents

Mexidol® is used in the first 10-14 days - 200-500 mg IV drip 2-4 times a day, then - 200-250 mg IM 2-3 times a day for 2 weeks.

For TBI and consequences of TBI

- IV drip of 200–500 mg 2–4 times a day, for 10–15 days.

For dyscirculatory encephalopathy in the decompensation phase

Mexidol® should be administered intravenously in a stream or drip at a dose of 200–500 mg 1–2 times a day for 14 days. Then - IM 100-250 mg/day over the next 2 weeks.

For course prophylaxis of dyscirculatory encephalopathy

the drug is administered intramuscularly at a dose of 200–250 mg 2 times a day for 10–14 days.

For mild cognitive impairment in elderly patients and anxiety disorders

the drug is used intramuscularly at a daily dose of 100–300 mg/day for 14–30 days.

In acute myocardial infarction as part of complex therapy

Mexidol® is administered intravenously or intramuscularly for 14 days against the background of traditional therapy for myocardial infarction, including nitrates, β-blockers, ACE inhibitors, thrombolytics, anticoagulant and antiplatelet agents, as well as symptomatic agents according to indications. In the first 5 days, to achieve maximum effect, it is advisable to administer the drug intravenously; in the next 9 days, Mexidol® can be administered intramuscularly. The drug is administered intravenously by drip infusion, slowly (to avoid side effects) in an isotonic sodium chloride solution or 5% dextrose (glucose) solution in a volume of 100–150 ml for 30–90 minutes. If necessary, slow jet administration of the drug is possible, lasting at least 5 minutes.

The drug is administered (IV or IM) 3 times a day, every 8 hours. The daily therapeutic dose is 6–9 mg/kg/day, a single dose is 2–3 mg/kg. The maximum daily dose should not exceed 800 mg, single dose - 250 mg.

For open-angle glaucoma of various stages as part of complex therapy

Mexidol® is administered intramuscularly at 100–300 mg/day, 1–3 times a day for 14 days.

For alcohol withdrawal syndrome

Mexidol® is administered in a dose of 200–500 mg intravenously or intramuscularly 2–3 times a day for 5–7 days.

In case of acute intoxication with antipsychotic drugs

the drug is administered intravenously at a dose of 200–500 mg/day for 7–14 days.

In acute purulent-inflammatory processes in the abdominal cavity (acute necrotizing pancreatitis, peritonitis)

For acute edematous (interstitial) pancreatitis

Mexidol® is prescribed 200–500 mg 3 times a day intravenously (in isotonic sodium chloride solution) and intramuscularly.
Mild severity of necrotizing pancreatitis
- 100–200 mg 3 times a day intravenously (in isotonic sodium chloride solution) and intramuscularly.
Moderate severity
- 200 mg 3 times a day intravenously (in isotonic sodium chloride solution).
Severe course
- in a pulse dosage of 800 mg on the first day, with a two-fold administration regimen;
then - 200–500 mg 2 times a day with a gradual reduction in the daily dose. Extremely severe course
- at an initial dosage of 800 mg/day until the manifestations of pancreatogenic shock are persistently relieved, upon stabilization of the condition - 300-500 mg 2 times a day intravenously (in isotonic sodium chloride solution) with a gradual decrease in the daily dosage.

Analogues of "Mexidol"

Mexidol analogues include a number of prescription and over-the-counter drugs:

"Glycine":
"Cerekard";
"Neurox";
"Combiplen";
"Caviton";
"Hypoxen";
"Armandine";
"Tenoten";
Astrox;
"Tryptophan";
Rilutek and many others.

The most popular analogues of Mexidol tablets are:

"Armadin" - also available in the form of solution and tablets. They are more expensive - for example, tablets can be purchased for at least 300 rubles, ampoules for injections - from 500 rubles. The medicine is taken to improve memory, especially in older patients. The product also helps improve performance and does not cause drowsiness.
“Glitsed” is a sedative drug that can be purchased at a price of 900 rubles. Improves blood supply to the brain, helps with recovery from traumatic brain injuries, and is used to treat a number of diseases of the nervous system.
“Antifront” is a blood pressure stabilizer that helps cope with headaches and dizziness. The price starts from 1500 rubles.
"Actovegin" is often prescribed in parallel with "Mexidol" because it has the same properties.

Indications for use

The drug is indicated for use in a number of cases:

neurological pathologies;
chronic cerebrovascular diseases;
cerebrovascular accident;
vegetative-vascular dystonia (mixed type);
cardiac ischemia (as an additional remedy);
brain hypoxia;
problems with memory, attention, speech;
constant stress;
skull injuries;
glaucoma;
alcoholism;
poisoning with neuroleptics;
increased anxiety.

Mexidol injection solution 5% 2ml amp 20 pcs

IM or IV (stream or drip). When administered by infusion, the drug should be diluted in 0.9% sodium chloride solution. Mexidol® is administered slowly over 5–7 minutes in a stream, and dropwise at a rate of 40–60 drops per minute. The maximum daily dose should not exceed 1200 mg.

For acute cerebrovascular accidents, Mexidol® is used in the first 10–14 days - 200–500 mg IV drip 2–4 times a day, then 200–250 mg IM 2–3 times a day for 2 weeks .

For traumatic brain injury and the consequences of traumatic brain injuries, Mexidol® is used for 10-15 days intravenously at a dose of 200–500 mg 2–4 times a day.

For dyscirculatory encephalopathy in the decompensation phase, Mexidol® should be prescribed intravenously in a stream or drip at a dose of 200–500 mg 1–2 times a day for 14 days. Then IM 100–250 mg/day over the next 2 weeks.

For a course of prophylaxis of discirculatory encephalopathy, the drug is administered intramuscularly at a dose of 200–250 mg 2 times a day for 10–14 days.

For mild cognitive impairment in elderly patients and anxiety disorders, the drug is used intramuscularly at a daily dose of 100–300 mg/day for 14–30 days.

In case of acute myocardial infarction, as part of complex therapy, Mexidol® is administered intravenously or intramuscularly for 14 days, against the background of traditional therapy for myocardial infarction, including nitrates, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, thrombolytics, anticoagulant and antiplatelet agents, as well as symptomatic means according to indications.

In the first 5 days, to achieve maximum effect, it is advisable to administer the drug intravenously; in the next 9 days, Mexidol® can be administered intramuscularly.

Intravenous administration of the drug is carried out by drip infusion, slowly (to avoid side effects) in a 0.9% sodium chloride solution or 5% dextrose (glucose) solution in a volume of 100–150 ml for 30–90 minutes. If necessary, a slow jet injection of the drug, lasting at least 5 minutes, is possible.

For open-angle glaucoma of various stages, as part of complex therapy, Mexidol® is administered intramuscularly at 100–300 mg/day, 1–3 times a day for 14 days.

For alcohol withdrawal syndrome, Mexidol® is administered in a dose of 200–500 mg intravenously or intramuscularly 2–3 times a day for 5–7 days.

In case of acute intoxication with antipsychotic drugs, the drug is administered intravenously at a dose of 200-500 mg/day for 7-14 days. In acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis), the drug is prescribed on the first day both in the preoperative and postoperative periods. The administered doses depend on the form and severity of the disease, the prevalence of the process, and variants of the clinical course. The drug should be discontinued gradually only after a stable positive clinical and laboratory effect.

For acute edematous (interstitial) pancreatitis, Mexidol® is prescribed 200–500 mg 3 times a day, intravenously (in 0.9% sodium chloride solution) and intramuscularly. Mild severity of necrotizing pancreatitis - 100-200 mg 3 times a day intravenously (in 0.9% sodium chloride solution) and intramuscularly. Moderate severity - 200 mg 3 times a day intravenously (in 0.9% sodium chloride solution). Severe course - in a pulse dosage of 800 mg on the first day with a double dose regimen; then 200–500 mg 2 times a day with a gradual reduction in the daily dose. Extremely severe course - at an initial dosage of 800 mg/day until the manifestations of pancreatogenic shock are persistently relieved, after stabilization of the condition, 300-500 mg 2 times a day intravenously (in 0.9% sodium chloride solution) with a gradual decrease in the daily dosage.

Drug interactions

The drug can be used in combination with most medications. Moreover, in some cases, Mexidol enhances the medicinal effect of such drugs:

antidepressants;
benzodiazepine drugs;
drugs against Parkinson's disease.

Simultaneous combination with alcoholic beverages is not allowed. It is known that Mexidol reduces the toxic effects associated with excess amounts of ethyl alcohol.

MEXIDOL solution for injection. IV, IM 50 mg/ml amp. 5 ml No. 10

Directions for use and doses

IM or IV (stream or drip).
When administered by infusion, the drug should be diluted in 0.9% sodium chloride solution.

Mexidol is administered in a stream slowly over 5-7 minutes, drip-wise at a rate of 40-60 drops per minute. The maximum daily dose should not exceed 1200 mg.

For acute cerebrovascular accidents

Mexidol is used in the first 10-14 days - 200-500 mg IV drip 2-4 times a day, then 200-250 mg IM 2-3 times a day for 2 weeks.

For traumatic brain injury and consequences of traumatic brain injury

Mexidol is used for 10-15 days intravenously, 200-500 mg 2-4 times a day.

For dyscirculatory encephalopathy in the decompensation phase

Mexidol should be prescribed intravenously in a stream or drip at a dose of 200-500 mg 1
-
2 times a day for 14 days. Then IM 100-250 mg/day. over the next 2 weeks.

For course prophylaxis of dyscirculatory encephalopathy

the drug is administered intramuscularly at a dose of 200-250 mg 2 times a day for 10-14 days.

For mild cognitive impairment in elderly patients and anxiety disorders

the drug is used intramuscularly at a daily dose of 100-300 mg/day for 14-30 days.

In acute myocardial infarction as part of complex therapy

Mexidol is administered intravenously or intramuscularly for 14 days, against the background of traditional therapy for myocardial infarction, including nitrates, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, thrombolytics, anticoagulant and antiplatelet agents, as well as symptomatic agents according to indications.

In the first 5 days, to achieve maximum effect, it is advisable to administer the drug intravenously; in the next 9 days, Mexidol can be administered intramuscularly. Intravenous administration of the drug is carried out by drip infusion, slowly (to avoid side effects) in a 0.9% sodium chloride solution or 5% dextrose (glucose) solution in a volume of 100-150 ml for 30-90 minutes. If necessary, a slow jet injection of the drug, lasting at least 5 minutes, is possible.

For open-angle glaucoma of various stages as part of complex therapy

Mexidol is administered intramuscularly at 100-300 mg/day, 1-3 times a day for 14 days.

For alcohol withdrawal syndrome

Mexidol is administered in a dose of 200-500 mg intravenously or intramuscularly 2-3 times a day for 5-7 days.

In case of acute intoxication with antipsychotic drugs

the drug is administered intravenously at a dose of 200-500 mg/day for 7-14 days.

In acute purulent-inflammatory processes of the abdominal cavity (acute necrotizing pancreatitis, peritonitis)

For acute edematous (interstitial) pancreatitis

Mexidol is prescribed 200-500 mg 3 times a day, intravenously (in 0.9% sodium chloride solution) and intramuscularly.

Mild severity of necrotizing
pancreatitis
- 100-200 mg 3 times a day intravenously (in 0.9% sodium chloride solution) and intramuscularly.

Moderate severity

- 200 mg 3 times a day, intravenously (in 0.9% sodium chloride solution).

Severe course

— in a pulse dosage of 800 mg on the first day, with a double administration regimen, then 200-500 mg 2 times a day with a gradual reduction in the daily dose.

Extremely severe course